“Drugs in the COVID-19 Pandemic: Analysis of the Commercialization of Azithromycin, Hydroxychloroquine, Ivermectin and Nitazoxanide in Brazil”. Research, Society and Development 11, no. 6 (April 24, 2022): e16711628726. Accessed December 5, 2025. https://rsdjournal.org/rsd/article/view/28726.